Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.40%||179.46||0.7%||$1371.52m|
|BMY||Bristol-Myers Squibb Co.||0.63%||76.67||1.0%||$1204.82m|
|MRK||Merck & Co., Inc.||0.45%||93.98||0.7%||$1144.89m|
|LLY||Eli Lilly & Co.||1.25%||302.57||1.1%||$903.32m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.66%||142.97||0.0%||$461.53m|
|HZNP||Horizon Therapeutics Plc||-3.29%||87.38||5.4%||$193.81m|
|NVO||Novo Nordisk A/S||0.07%||107.83||0.1%||$190.87m|
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.